Month: January 2025

PHOENIX, Jan. 30, 2025 /PRNewswire/ — Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity Capital”), a leading alternative asset manager, today announced the commitment of $25 million in growth capital to Wisetack, a leading pay-over-time platform for home services. Wisetack provides consumer…

CHICAGO, Jan. 30, 2025 /PRNewswire/ — Conagra Brands, Inc. (NYSE: CAG) will present at the 2025 CAGNY (Consumer Analyst Group of New York) Conference on Tuesday, Feb. 18, at 9 a.m. ET. Sean Connolly, president and chief executive officer of Conagra Brands, Dave Marberger, executive vice…

TORONTO, Jan. 30, 2025 /PRNewswire/ – Tucows Inc. (NASDAQ: TCX) (TSX: TC) today announced that it will report its financial results for the fourth quarter ended December 31, 2024, via news release on Thursday, February 13, 2025 at 5:05 p.m. ET. Concurrent with the dissemination of its…

NEW HAVEN, Conn., Jan. 30, 2025 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of patients with chronic cough in idiopathic pulmonary fibrosis (IPF)…

MEMPHIS, Tenn., Jan. 30, 2025 /PRNewswire/ — International Paper (NYSE: IP) today reported full-year 2024 net earnings of $557 million, or $1.57 per diluted share, and adjusted operating earnings (non-GAAP) of $400 million, or $1.13 per diluted share. Full-year net sales were $18.6…

INDIANA, Pa., Jan. 30, 2025 /PRNewswire/ — S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced fourth quarter and full year 2024 earnings. Net income of $33.1 million, or $0.86 per diluted share, for the fourth quarter of 2024 compared to net income of $32….

$0.46 GAAP EPS; $0.60 Operating EPS Operating EPS growth of 3% quarter-over-quarter and 28% year-over-year; FY2024 Operating EPS of $2.22 up 4% year-over-year Average deposit growth of 3% and Average loan growth of 0.4% quarter-over-quarter; Loans to deposits ratio improved further during…

SYDNEY, Jan. 30, 2025 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA) an oncology-focused drug development company, is pleased to announce the regulatory approval and launch of a clinical trial evaluating the combination of paxalisib and immunotherapy in patients with advanced…

ZURICH, Jan. 30, 2025 /PRNewswire/ — NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, is pleased to announce the…

SANDUSKY, Ohio, Jan. 30, 2025 /PRNewswire/ — Civista Bancshares, Inc. (NASDAQ:CIVB) (“Civista”) announced its unaudited financial results for the three- and twelve-month periods ending December 31, 2024. Fourth quarter and full-year 2024 highlights: Net income of $9.9 million, or $0.63…